पुणे, महाराष्ट्र, भारत मौसम पूर्वानुमान

There are no advertisements in the Pune yet
Tuesday (27.09)
Humid and Partly Cloudy
+24
  • °C
  • °F
+25°Feels like
3 mpsWind speed
10%Probability of precipitation
Tuesday
26%
2 mps
+20°
+28°
Wednesday
56%
2 mps
+20°
+28°
Thursday
76%
2 mps
+20°
+28°
Friday
93%
3 mps
+21°
+26°
Saturday
84%
3 mps
+20°
+27°
Sunday
60%
3 mps
+19°
+28°
Monday
24%
3 mps
+18°
+29°
Tuesday
9%
3 mps
+19°
+29°
Other News Pune

Biosimulation Market SWOT Analysis, Key Players, Analysis and Forecasts Till 2027


Market Highlights

According to MRFR analysis, Biosimulation Market is expected to register a CAGR of 15.9% during the forecast period of 2019 to 2025 and is likely to be valued at USD 4.4 Billion by 2025.

Biosimulation is a tool used for the prediction of the outcomes of existing clinical trials associated with innovation and new drug development.

The growth of the Global biosimulation Market is determined by numerous factors such as the growing adoption of biosimulation software by regulatory bodies, increasing healthcare expenditure, increasing use of pharmacokinetic & pharmacodynamic modelling in pre-clinical development and rising need to reduce the drug development costs. However, lack of standardization in biosimulation methodology and lack of trained professionals for monitoring biosimulation software are likely to hamper the growth of the global biosimulation market during the forecast period.

Several market players currently dominate the Global Biosimulation Market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in September 2019, Certara Inc. launched version 8.2 of Phoenix, the most advanced and widely used validated software for PK, PD, and toxicokinetic modeling and simulation worldwide.

Key Players

Some of the Key Players in the Global Biosimulation Market are Dassault Systèmes (France), Certara USA, Inc. (US), Simulation Plus (US), Schrödinger (US), Chemical Computing Group (Canada), Physiomics (UK), In Silico Biosciences (US), Advanced Chemistry Development, Inc. (Canada), Genedata AG (Switzerland), Nuventra Pharma (US), Evidera (US), Leadinvent Technologies (India), LeadScope, Inc. (US), Rosa (US) and INOSIM Software GmbH (Germany).

Segmentation

The Global Biosimulation Market has been segmented based on product, application, delivery model and end users.

The market, based on product, has been divided into software and services. The software segment is further segmented into PK/PD (pharmacokinetic/pharmacodynamic) modeling and simulation software, molecular modeling and simulation software, PBPK (physiologically based pharmacokinetic) modeling and simulation software, toxicity prediction software, trial design software, and others. The services segment is further segmented into in-house services and contract services. The software segment is likely to hold the maximum market share in the global biosimulation market owing to growing adoption of biosimulation software by pharmaceutical and research organizations and the increasing R&D investment for pharmaceutical research.

The global biosimulation market based on the application has been segregated into drug development, drug discovery, and others. The drug development segment is expected to hold a larger share of the market share owing to the rising adoption of biosimulation tool for the drug development process.

The delivery model segment of the market is divided into subscription models and ownership models.

Based on end users, the global biosimulation market has been segmented into pharmaceutical and biotechnology companies, contract research organizations, research institutes, regulatory authorities, and others. Rising adoption of inorganic growth strategies by different biosimulation service providers is likely to boost the adoption of biosimulation solutions in the pharmaceuticals and biotechnology companies.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Americas has been segmented into North America and Latin America, with the North American market being divided into the US and Canada. The Americas is projected to hold the largest market share owing to the increasing R&D spending by pharmaceutical and biotechnology companies in the region and growing number of clinical trials & drug development practices.

The European biosimulation market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The biosimulation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Rising geriatric population and the presence of a large patient pool, are the key factors responsible for the fastest growth of the market in Asia-Pacific. The biosimulation market in the Middle East & Africa has been divided into the Middle East and Africa.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Show more
0
4

Allergy Immunotherapy Market 2022 Industry Overview, Analysis and Forecast by 2027


Market Overview

the allergy immunotherapy market in the global market will grow at a higher CAGR of 10.85% by the end of the forecasted period and account for a market share of approximately 4.32 billion by the end of the forecasted period from 2022 to 2027.

Market Dynamics

The market for medications to treat a variety of disorders is growing as a result of the rising demand. A growing number of allergic ailment pills have been manufactured by major market participants as a result of increased research efforts to meet the market's demand. Because of an increase in personal disposable income, consumers can afford to spend more money on allergy-related therapies, creating an opportunity for the expansion of the allergy immunotherapy market throughout the forecast period. As a result, the global allergy immunotherapy market has grown as a result of rising pollution levels, higher alcohol consumption, and changes in dietary patterns and lifestyles.

The global allergy immunotherapy market is growing at a rapid pace, but several issues, such as skin-related disorders, gastrointestinal and respiratory disorders, linked with the treatment, limit its expansion. The high cost of allergy immunotherapy treatment is another factor that limits the market's expansion.

In the wake of the COVID-19 epidemic, the world economy took a heavy toll as it provided significant obstacles to a wide range of industries. The rising COVID-19 count, on the other hand, was beneficial for the adoption of allergy immunotherapy in the treatment of IgE-mediated allergies and for the comprehension of immunological effects on affected individuals. There are many doctors and allergists that use this method on a regular basis to treat patients who are afflicted with the disease.

Competitive Dynamics

The notable players of the market are ALK Abello (UK), Allergy Therapeutic (UK), Circassia (UK), DVB Technologies (UK), (UK), and HAL Allergy Group (UK), Merck KGaA (Allergopharma), Stallergenes Greer (UK).

Segmental Analysis

The worldwide Allergy Immunotherapy Market has been segmented based on the kind of allergy and the treatment method used.

Allergic rhinitis, Rhinitis, and Peanut allergies are the three main categories of allergy immunotherapy in the global market.

Based on the type of treatment, allergy immunotherapy has been segmented into Sublingual immunotherapy, SCIT, and Specific immunotherapy (SIT).

Regional Overview

As a result of the strong presence of some of the major industry players in Europe, the allergy immunotherapy market in Europe is expected to grow significantly through 2027. There is a considerable number of people in the area who suffer from allergies, asthma, and food allergies. In addition, the rise in the number of allergy drop approvals will further accelerate the market's growth. In addition, there has been an increase in the number of allergy drops approved for use in Europe. The introduction of allergy immunotherapy in Europe and North America has significant contrasts and parallels. Allergen extracts are available in a variety of forms, with varying degrees of accessibility and efficacy. In Europe, for example, allergen-specific immunotherapy treatment is dominated by SLIT.

In fact, only a small number of allergists in the United States use it. Despite this, both regions place an emphasis on research and development in order to create allergen-specific immunotherapy methods that are both successful and safe.

Asia Pacific, on the other hand, is expected to grow at the fastest rate during the forecast period. The expansion of the market can be due to the strong presence of leading businesses in expanding Asian markets and investments in SLIT enhancement, standardization of dosage, and long-term results evaluation.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Show more
0
5

Vascular Closure Devices Market Shares Analysis, Key Development Strategies and Forecasts Till 2027


Key Players:

Some of the key players in the global intraocular lens market are Abbott Laboratories, Terumo Corporation, Cardinal Health Inc., Cardiva Medical Inc., Morris Innovative, Inc., Medtronic plc, Essential Medical, Inc., Merit Medical Systems, Inc., TZ Medical, Inc., Vasorum Ltd., Transluminal Technologies LLC, Vascular Closure Systems, Inc., Vivasure Medical Ltd., among others.

Market Highlights

It is estimated that the global Vascular Closure Devices Market Trends is expected to register a CAGR ~ 6.8% during the forecast period of 2018–2023. The global vascular closure devices market is expected to witness tremendous growth owing to the rising prevalence of numerous types of cardiovascular as well as neurovascular diseases. Other key factors such as the untapped market opportunities in emerging countries, growing investments by government organizations, increasing adoption rate of minimally invasive techniques are contributing towards the growth of the market. However, factors such as lack of trained medical professionals, and the post-operative complications are expected to curb the growth of the market during the forecast period.

Segmentations:

Currently, the global vascular closure devices market is dominated by numerous players. The major players in this market are involved in new product launches, strategic partnerships and collaborations to increase their product portfolio. For example, in June 2018, Biomerics, a medical device contract manufacturer announced the acquisition of FutureMatrix Interventional, Inc. The company aims to expand its portfolio of interventional catheters used in cardiovascular and urology fields, thus strengthening its position in the market.

The global vascular closure devices market is segmented on the basis of product type, access, procedures, application, and end user.

Regional Analysis:

On the regional basis, the vascular closure devices market in the Americas is predicted to dominate the market during the forecast period. The North American region holds substantial share in the global market. This owes to the rise in the government initiatives, and the increased prevalence of coronary diseases in these regions. For instance, according to the data published in 2015 by the American Heart Association (AHA), about one in 7 deaths in the US is caused by coronary heart disease. Also, numerous major players are based in the US, owing to which the US has become a center for innovation in the vascular closure devices market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Show more
0
4
Other News India
youtube-poster

Doston Chita Dharti ka Sabse Tej Janwar hai, yah palak jhapakte hi 100 kilometer prati ghante se adhik ki raftar pakad sakta hai

फिर वी ek visheshta inke dusre gunon ko kam kar deti hai,

patla aur halka sharir hone ke Karan hi chita itni Tej दौर pata hai,


kintu yah patla aur halka sharir chita ko Anya badi billiyon ki tulna mein kam shaktishali bhi _ banaa deta hai_ yahi vajah hai ki Chita ko

na chei maarte hue Apne shikar ko teji se todkar pakad to leta hai kintu shikar ko maar dalne ke liye

तो उल्टा चीते की ही जान के लाले पड़ जाते हैं।


या इस वीडियो में यह माता चीता कई दिनों से शिकार की तलाश में थी, सिर्फ यही नहीं बल्कि इसके छोटे बच्चे भी भूख से व्याकुल थे, इसलिए दौड़ लगाती है ।


और एक बड़े बेशक नदीम पाला को पकड़ लेती है इसके छोटे शिकार में अपनी मां की मदद करते दिखाई पड़ रहे हैं !


[ बड़े आकार का नर इंपाला chiyay से अधिक ताकतवर हो सकता है और , सबसे बड़ी बात यह किसके पास अपनी रक्षा के लिए करीब 3 फीट लंबे और भेद होते हैं , चिता पर हमला बोल देता है इस हमले को यह कमजोर , नहीं संभाल पाती काफी दूर तक चीता को घसीटते हुए ले जाता है और इसका एक शिकारी chor kar antata pichay आना पड़ा।


[अभी आप शिकायत नहीं कर पाएगी एक अन्य वीडियो में भी आप एक है काम वाले चिता को देख सकते हैं _ ]


यह भी छोटे गांव को वाली उस्मा धारिता है और इसकी टांग घायल होने का सीधा अर्थ यह है कि अब यह तेजी से नहीं दौड़ पाएगी और शिकार भी नहीं कर पाएगी


मतलब ना सिर्फ यह खुद बल्कि जल्द ही इसके चलते मारे जाएंगे वैसे ही यह चलते मारे जाए किंतु के लिए सबसे बड़ा खतरा शेर होते हैं विचारों को मार डालते हैं ऐसा क्यों होता है।

[email protected]__________________________________________________


Show more
0
7
https://avalanches.com/in/jagraon_hungerdeficiency_free_india_equal_access_to_nutrition4429660_23_09_2022

Hunger:-Deficiency Free India: Equal Access to Nutrition!


What is hunger?

According to politics, humanitarian aid, and the social sciences, hunger is the need for a sustained period of nutrients for a person’s physical or financial capabilities to eat enough food.


*Hunger in India* .

India has been facing serious hunger crisis for a long time. As per the Global Hunger Index report 2020 which was released by Washington-based International Food Policy Research Institute (IFPRI), India has slipped down to 101th rank among 116 countries based on three key indicators:-


(i) Prevalence of wasting and stunting among children under 5 years of age


(ii) Child mortality under 5


(iii) The proportion of undernourished in the population.


*Causes of hunger in India.*


✓Failures to invest in agriculture, supporting small farms, to name a few are some of the causes which have stunted the smooth sail of India, a fast-growing economy in the world. The rate of malnutrition is worse in India.

✓Failure of food schemes. A disparity between the real execution of schemes for the greater good of citizens.

✓The inefficient management of food available. According to a report by the United Nations, 40% of the total produce is either lost or wasted.

✓Poverty is one of the most critical factors that contribute to the prevailing hunger crisis in India. The shocking fact remains that two-thirds of the people living in India are poverty-stricken.


*How can we improve?*

India needs a practical multi-dimensional approach to win over the food crisis.

✓Government must ensure that small and marginal farmers can grow more crops in a year.

✓The government should be implemented schemes to reach the lowest strata of uneducated, unaware and unemployed citizens like One Nation, One Ration Card.

✓Last but not least people contribute to provide food to needed people.

Hamri pachan NGO also work on hungry crirs. Volunteer contect with NGO and give own contribution.


*"Alone we can do so little; together we can do so much."* – _Helen Keller_


So start with Hamari Pahchan NGO to overcome the hungry and make healthy India .


Thanks

Beant kaur

Show more
0
7